| CVSS Meta Temp Score | Current Exploit Price (≈) | CTI Interest Score |
|---|---|---|
| 6.0 | $5k-$25k | 0.00 |
Summary
A vulnerability marked as critical has been reported in Red Hat Keycloak. Affected by this issue is some unknown functionality of the component Admin Console. Performing a manipulation results in privileges management. This vulnerability is known as CVE-2025-7784. No exploit is available.
Details
A vulnerability classified as critical has been found in Red Hat Keycloak (the affected version is unknown). This affects an unknown code of the component Admin Console. The manipulation with an unknown input leads to a privileges management vulnerability. CWE is classifying the issue as CWE-269. The product does not properly assign, modify, track, or check privileges for an actor, creating an unintended sphere of control for that actor. This is going to have an impact on confidentiality, integrity, and availability. The summary by CVE is:
A flaw was found in the Keycloak identity and access management system when Fine-Grained Admin Permissions(FGAPv2) are enabled. An administrative user with the manage-users role can escalate their privileges to realm-admin due to improper privilege enforcement. This vulnerability allows unauthorized elevation of access rights, compromising the intended separation of administrative duties and posing a security risk to the realm.
The advisory is shared at bugzilla.redhat.com. This vulnerability is uniquely identified as CVE-2025-7784. The exploitability is told to be easy. Neither technical details nor an exploit are publicly available. The price for an exploit might be around USD $5k-$25k at the moment (estimation calculated on 07/23/2025). MITRE ATT&CK project uses the attack technique T1068 for this issue.
There is no information about possible countermeasures known. It may be suggested to replace the affected object with an alternative product.
The vulnerability is also documented in the vulnerability database at CERT Bund (WID-SEC-2025-1607). If you want to get the best quality for vulnerability data then you always have to consider VulDB.
Affected
- Open Source Keycloak
Product
Vendor
Name
License
Website
- Vendor: https://www.redhat.com/
CPE 2.3
CPE 2.2
CVSSv4
VulDB Vector: 🔒VulDB Reliability: 🔍
CVSSv3
VulDB Meta Base Score: 6.0VulDB Meta Temp Score: 6.0
VulDB Base Score: 5.5
VulDB Temp Score: 5.5
VulDB Vector: 🔒
VulDB Reliability: 🔍
CNA Base Score: 6.5
CNA Vector: 🔒
CVSSv2
| AV | AC | Au | C | I | A |
|---|---|---|---|---|---|
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| Vector | Complexity | Authentication | Confidentiality | Integrity | Availability |
|---|---|---|---|---|---|
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
VulDB Base Score: 🔒
VulDB Temp Score: 🔒
VulDB Reliability: 🔍
Exploiting
Class: Privileges managementCWE: CWE-269 / CWE-266
CAPEC: 🔒
ATT&CK: 🔒
Physical: No
Local: No
Remote: Yes
Availability: 🔒
Status: Not defined
EPSS Score: 🔒
EPSS Percentile: 🔒
Price Prediction: 🔍
Current Price Estimation: 🔒
| 0-Day | Unlock | Unlock | Unlock | Unlock |
|---|---|---|---|---|
| Today | Unlock | Unlock | Unlock | Unlock |
Threat Intelligence
Interest: 🔍Active Actors: 🔍
Active APT Groups: 🔍
Countermeasures
Recommended: no mitigation knownStatus: 🔍
0-Day Time: 🔒
Timeline
07/18/2025 Advisory disclosed07/18/2025 VulDB entry created
07/23/2025 VulDB entry last update
Sources
Vendor: redhat.comAdvisory: bugzilla.redhat.com
Status: Confirmed
CVE: CVE-2025-7784 (🔒)
GCVE (CVE): GCVE-0-2025-7784
GCVE (VulDB): GCVE-100-316845
CERT Bund: WID-SEC-2025-1607 - Keycloak: Schwachstelle ermöglicht Privilegieneskalation
Entry
Created: 07/18/2025 09:02Updated: 07/23/2025 02:19
Changes: 07/18/2025 09:02 (49), 07/21/2025 16:31 (7), 07/23/2025 02:19 (13)
Complete: 🔍
Cache ID: 216::103
If you want to get the best quality for vulnerability data then you always have to consider VulDB.
No comments yet. Languages: en.
Please log in to comment.